drugset / Trial / NCT00422318

Treatment of Hyperuricemia in Patients With Heart Failure

NCT00422318

Phase 4 Completed Tottori University Hospital
RandomizedCrossoverDouble-blindTreatment

Summary

The study aims to assess (I) the contribution of UA itself to the CHF pathophysiology and (II) to test the effect of lowering UA by uricosuric treatment in CHF.

Timeline

Start
2004-01
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzbromarone Small molecule

Indications